Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Analytic validation and clinical utilization of the comprehensive genomic profiling test, GEM ExTra®

9 Apr 2021

Abstract excerpt

// Tracey White 1 , * , Szabolcs Szelinger 1 , * , Janine LoBello 1 , Amy King 1 , Jessica Aldrich 1 , Nathan Garinger 1 , Matthew Halbert 1 , Ryan F. Richholt 1 , Stephen D. Mastrian 1 , Cody Babb 1 , Audrey A. Ozols 1 , Laurie J. Goodman 1 , Gargi D. Basu 1 and Thomas Royce 1 1 Ashion Analytics, LLC, Phoenix, Arizona 85004, USA * These authors contributed equally to this work Correspondence to: Thomas Royce,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Genetic factors in colorectal cancer
Share to Lung Cancer Treatments and Mutations

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33889297
DOI: 10.18632/oncotarget.27945

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 10 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Analytic validation and clinical utilization of the comprehensive genomic profiling test, GEM ExTra®PMID 33889297Read ↗

Clinical and Technical Validation of OncoIndx® Assay – A Comprehensive Genome Profiling Assay for Pan-Cancer InvestigationsSemantic proximity Read ↗

Analytical and Clinical Validation of a Target-Enhanced Whole Genome Sequencing-Based Comprehensive Genomic Profiling Test.Semantic proximity Read ↗

Analytical and clinical validation of a targeted-enhanced whole genome sequencing-based comprehensive genomic profiling testSemantic proximity Read ↗

Assessment of Clinical Benefit of Integrative Genomic Profiling in Advanced Solid TumorsSemantic proximity Read ↗

Feasibility of whole‐genome sequencing‐based tumor diagnostics in routine pathology practiceSemantic proximity Read ↗

An absolute approach to using whole exome DNA and RNA workflow for cancer biomarker testingSemantic proximity Read ↗

Analytical validation and clinical utilization of K-4CARE<sup>TM</sup>: a comprehensive genomic profiling assay with personalized MRD detectionSemantic proximity Read ↗

Automated next-generation profiling of genomic alterations in human cancers.Semantic proximity Read ↗

Real‐World Data Analysis of Genomic Alterations Detected by a Dual DNA – RNA Comprehensive Genomic Profiling TestSemantic proximity Read ↗

Nationwide genomic data analysis of central nervous system tumors in Japan based on C-CAT database.Semantic proximity Read ↗

Comprehensive genomic profiling for oncological advancements by precision medicine.Semantic proximity Read ↗

Translational and clinical comparison of whole genome and transcriptome to panel sequencing in precision oncologySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.